Schizophrenia News and Research

Latest Schizophrenia News and Research

Adolescents with psychosis face long treatment delays

Adolescents have a duration of untreated psychosis that is approximately twice that seen in adults, UK study findings show.

20 Sep 2013

Visual clue to schizophrenia pathology

Researchers say that retinal imaging could be a useful tool for studying some of the pathologic processes associated with schizophrenia.

19 Sep 2013

Omeros announces initiation of enrollment in OMS824 Phase 2 trial for schizophrenia

Omeros Corporation today announced initiation of enrollment in a Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 inhibitor. The trial will evaluate the compound's tolerability, safety, pharmacokinetics, potential interactions with concomitant antipsychotic medications, and a battery of cognitive tests in patients with stable schizophrenia.

19 Sep 2013

Scientist develop novel system to monitor behavior of patients suffering from schizophrenia

Schizophrenia is a potentially debilitating mental illness affecting a person's thought processes, perception, language and sense of oneself.

19 Sep 2013

Toxoplasma infection makes mice fearless

The Toxoplasma parasite can be deadly, causing spontaneous abortion in pregnant women or killing immune-compromised patients, but it has even stranger effects in mice.

19 Sep 2013

Neuropsychologic decline precedes schizophrenia onset

Researchers have confirmed that neuropsychologic functioning declines in individuals with schizophrenia from before to after illness onset.

18 Sep 2013

Children with 22q11.2 deletion syndrome may often be misdiagnosed to have autism

Children with a genetic disorder called 22q11.2 deletion syndrome, who frequently are believed to also have autism, often may be misidentified because the social impairments associated with their developmental delay may mimic the features of autism, a study by researchers with the UC Davis MIND Institute suggests.

18 Sep 2013

Cardiovascular mortality in schizophrenia may be underestimated

Cardiovascular causes account for about a quarter of deaths of patients with schizophrenia and may also contribute to the high rate of unexplained deaths, say researchers.

17 Sep 2013

Oxytocin shows evidence of therapeutic value for autism, schizophrenia

The hormone oxytocin could play a role in treating psychiatric disorders such as autism and schizophrenia, according to a review article in the September Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

17 Sep 2013

‘Risk circuits’ for schizophrenia refined

A study sheds further light on the brain circuits that may underlie risk for schizophrenia.

16 Sep 2013

Adolescent emotion unravels social impact of psychotic symptoms

Emotional or behavioral problems may explain why some adolescents with psychotic symptoms find it hard to interact socially, researchers highlight.

12 Sep 2013

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

Psychiatrist documents how schizophrenia impacts brain tissue

It's hard to fully understand a mental disease like schizophrenia without peering into the human brain. Now, a study by University of Iowa psychiatry professor Nancy Andreasen uses brain scans to document how schizophrenia impacts brain tissue as well as the effects of anti-psychotic drugs on those who have relapses.

12 Sep 2013

Research suggests possibility of using cell transplants to treat schizophrenia

Research from the School of Medicine at The University of Texas Health Science Center at San Antonio suggests the exciting possibility of using cell transplants to treat schizophrenia.

10 Sep 2013

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Scientists at the Centre for Addiction and Mental Health (CAMH) and University Health Network (UHN) have found a new link between early-onset Parkinson's disease and a piece of DNA missing from chromosome 22. The findings help shed new light on the molecular changes that lead to Parkinson's disease.

10 Sep 2013

Plasma marker inflames schizophrenia risk

Elevated plasma levels of the inflammatory molecule C-reactive protein may be a marker of an increased risk for developing schizophrenia, a study suggests.

6 Sep 2013

Negative symptom clue to smoking in schizophrenia patients

Patients with schizophrenia may have a preponderance to cigarette smoking because it reduces negative symptom severity, researchers report.

5 Sep 2013

Longer looks: Phenomenal growth of the Cleveland Clinic prompts hopes for the city; the bittersweet decision to donate organs

Delos M. "Toby" Cosgrove arrived at the Cleveland Clinic in 1975 as an "incredibly poor" 34-year-old dreaming of a life as a cardiac surgeon. … As the years passed he became well-known for pioneering the replacement of heart valves, eventually assuming the chair of the department of cardiothoracic surgery.

From Medtronic 5 Sep 2013

Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

A stressful pregnancy might be the last thing a future mother needs, but it is to her unborn baby that this stress spells real trouble. All because stress hormones (called glucocorticoids or GCs) can disturb normal foetal brain development, leading to behavioural and/or emotional problems later in life.

5 Sep 2013

Tel Aviv University researchers use zoological methods to study people with serious mental disorders

Because animals can't talk, researchers need to study their behavior patterns to make sense of their activities. Now researchers at Tel Aviv University are using these zoological methods to study people with serious mental disorders.

5 Sep 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Adolescents with psychosis face long treatment delays

Visual clue to schizophrenia pathology

Omeros announces initiation of enrollment in OMS824 Phase 2 trial for schizophrenia

Scientist develop novel system to monitor behavior of patients suffering from schizophrenia

Toxoplasma infection makes mice fearless

Neuropsychologic decline precedes schizophrenia onset

Children with 22q11.2 deletion syndrome may often be misdiagnosed to have autism

Cardiovascular mortality in schizophrenia may be underestimated

Oxytocin shows evidence of therapeutic value for autism, schizophrenia

‘Risk circuits’ for schizophrenia refined

Adolescent emotion unravels social impact of psychotic symptoms

Omeros announces positive data from OMS824 Phase 1 clinical trial

Psychiatrist documents how schizophrenia impacts brain tissue

Research suggests possibility of using cell transplants to treat schizophrenia

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Plasma marker inflames schizophrenia risk

Negative symptom clue to smoking in schizophrenia patients

Longer looks: Phenomenal growth of the Cleveland Clinic prompts hopes for the city; the bittersweet decision to donate organs

Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

Tel Aviv University researchers use zoological methods to study people with serious mental disorders

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in